Vnitr Lek 2021, 67(Suppl.C):17-22 | DOI: 10.36290/vnl.2021.102

Nové pohledy na léčbu arytmií

MUDr. Zuzana Zafarová

Sympozium společnosti PRO.MED.CS Praha a.s., které proběhlo v rámci XXIX. výročního sjezdu České kardiologické společnosti 13. 5. 2021, bylo zaměřené na moderní techniky v léčbě srdečních arytmií. Prof. Kautzner se ve své přednášce věnoval přínosu ablace fibrilace síní (FS), významu udržení sinusového rytmu pro prognózu nemocných a novým technologiím, které umožní provedení výkonu u většího počtu pacientů s větší účinností. MUDr. Hašková připomněla a na výsledcích klinických hodnocení doložila, že kompenzace ovlivnitelných rizikových faktorů, jako je obezita, nedostatek pohybové aktivity, konzumace alkoholu, kouření, může snížit výskyt FS. MUDr. Čihák prezentoval data, která ukazují přínos ablace FS u pacientů se srdečním selháním vzniklým v důsledku FS a u nově zjištěné FS u pacientů se srdeční resynchronizační léčbou (CRT). Vysvětlil také přínos ablace AV junkce u nemocných s CRT stimulací a FS, kdy není zvažována selektivní ablace pro FS. Doc. Peichl se věnoval řešení arytmické bouře. Ukázal, že farmakoterapeuticky je nejvhodnější kombinace neselektivního β-blokátoru a amiodaronu, u primárních arytmických syndromů pak specifická antiarytmická léčba. Pro akutní potlačení bouře lze využít sedaci nebo opich ganglion stellatum. Účinnou metodou pro prevenci recidiv komorových arytmií je včasná katetrizační ablace. Doc. Wichterle popsal indikace a provedení kardioneuroablace jako perspektivní léčebné metody v případě reflexních kardioinhibičních synkop a symptomatické bradyarytmie. Jde o bezpečnou a vysoce účinnou metodu, která představuje alternativu implantace pacemakeru. Na sympoziu také představil doc. Kettner 3. přepracované a doplněné vydání knihy Akutní kardiologie (Grada), kterou připravil kolektiv autorů z IKEM a která je určena lékařům a zdravotním sestrám na koronárních jednotkách, JIP, odděleních urgentního příjmu i interních odděleních.

Published: October 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zafarová Z. Nové pohledy na léčbu arytmií. Vnitr Lek. 2021;67(Suppl. C - Novinky v k):17-22. doi: 10.36290/vnl.2021.102.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Savelieva I, Kourliouros A, Camm J. Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol 2010; 381(3): 1-13. Go to original source... Go to PubMed...
    2. Arbelo E, Brugada J, Blomström-Lundqvist C, Laroche C, Kautzner J, Pokushalov E, Raatikainen P, Efremidis M, Hindricks G, Barrera A, Maggioni A, Tavazzi L, Dagres N; on the behalf of the ESC-EHRA Atrial Fibrillation Ablation Long-term Registry Investigators. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J 2017; 38(17): 1303-1316. Go to original source... Go to PubMed...
    3. Caldeira D, David C, Sampaio C. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials. Arch Cardiovasc Dis. 2012; 105(4): 226-238. Go to original source... Go to PubMed...
    4. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D; CASTLE-AF Investigators. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 2018; 378(5): 417-427. Go to original source... Go to PubMed...
    5. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL; CABANA Investigators. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA 2019; 321(13): 1261-1274. Go to original source... Go to PubMed...
    6. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 2020; 383(14): 1305-1316. Go to original source... Go to PubMed...
    7. Reddy VY, Anter E, Rackauskas G, Peichl P, Koruth JS, Petru J, Funasako M, Minami K, Natale A, Jais P, Nakagawa H, Marinskis G, Aidietis A, Kautzner J, Neuzil P. Lattice-Tip Focal Ablation Catheter That Toggles Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation: A First-in-Human Trial. Circ Arrhythm Electrophysiol 2020; 13(6): e008718. Go to original source... Go to PubMed...
    8. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P. Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation. J Am Coll Cardiol 2019; 74(3): 315-326. Go to original source... Go to PubMed...
    9. Kloosterman M, Oldgren J, Conen D, Wong JA, Connolly SJ, Avezum A, Yusuf S, Ezekowitz MD, Wallentin L, Ntep-Gweth M, Joseph P, Barrett TW, Tanosmsup S, McIntyre WF, Lee SF, Parkash R, Amit G, Grinvalds A, Van Gelder IC, Healey JS. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Europace. 2020 Jun 1; 22(6): 870-877. Go to original source... Go to PubMed...
    10. Sramko M, Wichterle D, Melenovsky V, Clemens M, Fukunaga M, Peichl P, Aldhoon B, Cihak R, Kautzner J. Resting and Exercise-Induced Left Atrial Hypertension in Patients With Atrial Fibrillation: The Causes and Implications for Catheter Ablation. JACC Clin Electrophysiol. 2017 May; 3(5): 461-469. Go to original source... Go to PubMed...
    11. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, Twomey D, Elliott AD, Kalman JM, Abhayaratna WP, Lau DH, Sanders P. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 2015; 65(20): 2159-2169. Go to original source... Go to PubMed...
    12. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 2014; 64(21): 2222-2231. Go to original source... Go to PubMed...
    13. Voskoboinik A, Prabhu S, Ling LH, Kalman JM, Kistler PM. Alcohol and Atrial Fibrillation: A Sobering Review. J Am Coll Cardiol. 2016; 68(23): 2567-2576. Go to original source... Go to PubMed...
    14. Aune D, Schlesinger S, Norat T, Riboli E. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018; 25(13): 1437-1451. Go to original source... Go to PubMed...
    15. Khan H, Kella D, Rauramaa R, Savonen K, Lloyd MS, Laukkanen JA. Cardiorespiratory fitness and atrial fibrillation: A population-based follow-up study. Heart Rhythm 2015; 12(7): 1424-1430. Go to original source... Go to PubMed...
    16. Mustafa U, Atkins J, Mina G, Dawson D, Vanchiere C, Duddyala N, Jones R, Reddy P, Dominic P. Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies. Open Heart 2019; 6(1): e000937. Go to original source... Go to PubMed...
    17. Waranugraha Y, Rizal A, Setiawan D, Aziz IJ. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis. Indian Pacing Electrophysiol J 2021; 21(2): 101-111. Go to original source... Go to PubMed...
    18. Muthumala A, Vijayaraman P. His-Purkinje conduction system pacing and atrioventricular node ablation. Herzschrittmacherther Elektrophysiol. 2020; 31(2): 117-123. Go to original source... Go to PubMed...
    19. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373-498. Go to original source... Go to PubMed...
    20. Jodko Ł, Kornacewicz-Jach Z, Kaźmierczak J, Rzeuski R, Zielonka J, Kaliszczak R, Safranow K. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice. Cardiol J 2009; 16(5): 432-439.
    21. Chatzidou S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, Kosmopoulos M, Papadopoulou E, Vasilopoulos G, Rokas S. Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator. J Am Coll Cardiol 2018; 71(17): 1897-1906. Go to original source... Go to PubMed...
    22. Martins RP, Urien JM, Barbarot N, Rieul G, Sellal JM, Borella L, Clementy N, Bisson A, Guenancia C, Sagnard A, Schumacher S, Gandjbakhch E, Duchateau J, Tixier R, Goepp A, Hamon D, Lellouche N, Champ-Rigot L, Milliez P, Marijon E, Varlet E, Garcia R, Degand B, Bouju P, Mabo P, Leclercq C, Behar N, Pavin D, de Chillou C, Sacher F, Galand V. Effectiveness of Deep Sedation for Patients With Intractable Electrical Storm Refractory to Antiarrhythmic Drugs. Circulation 2020; 142(16): 1599-1601. Go to original source... Go to PubMed...
    23. Vergara P, Tung R, Vaseghi M, Brombin C, Frankel DS, Di Biase L, Nagashima K, Tedrow U, Tzou WS, Sauer WH, Mathuria N, Nakahara S, Vakil K, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Vunnam R, Lakireddy D, Burkhardt JD, Correra A, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Della Bella P. Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival. Heart Rhythm 2018; 15(1): 48-55. Go to original source... Go to PubMed...
    24. Aldhoon B, Wichterle D, Peichl P, Čihák R, Kautzner J. Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm. PLoS One 2017; 12(2): e0171830. Go to original source... Go to PubMed...
    25. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39(21): 1883-1948. Go to original source... Go to PubMed...
    26. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, Wieling W, Beiras X, Deharo JC, Russo V, Tomaino M, Sutton R; International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012; 125(21): 2566-2571. Go to original source... Go to PubMed...
    27. Brignole M, Russo V, Arabia F, Oliveira M, Pedrote A, Aerts A, Rapacciuolo A, Boveda S, Deharo JC, Maglia G, Nigro G, Giacopelli D, Gargaro A, Tomaino M; BioSync CLS trial Investigators. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J 2021; 42(5): 508-516. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.